Facial fat grafting is often described as natural filler. The phrase is attractive and it is incomplete, because it borrows the expectations of a product for something that behaves like tissue.
Fat grafting is a biologic volume transfer. It is not instant, it does not behave identically in every patient, and the outcome depends on technique, on the quality of the recipient tissue, and on how the body heals. Performed with restraint it can restore facial support in a way that looks calm and lasts. Performed as a volume exercise it produces the heaviness that patients came in hoping to avoid.
What the procedure actually does
Facial fat grafting is a procedure in which a patient’s own fat is harvested from a donor area, processed, and then injected into selected facial regions to restore volume and improve contour. It is commonly used for age-related volume loss, hollowing and contour imbalance.
It can be performed on its own, or combined with facelift surgery when both repositioning and volume restoration are needed. That combination is not an upsell — it reflects the fact that facial ageing is not only sagging. It is also volume change and redistribution, and those two mechanisms need different answers.
Descent and deflation are not the same problem
The anatomical complexity begins with distinguishing between the two. If a face is primarily sagging, adding volume can create heaviness rather than support. If a face is primarily hollow, lifting alone can look tight without restoring softness.
Many patients have both, in different proportions. A coherent plan separates the mechanisms before it treats them, because the same complaint — looking tired, looking older — can arise from either. This is the single most useful distinction to establish before any technique is discussed.
Descent, deflation, or both
| Feature | Deflation dominant | Descent dominant | Both present |
|---|---|---|---|
| What the face is doing | Volume has been lost; hollowing and harsher shadows appear even at stable weight | Tissue has moved downwards; the weight of the face has shifted rather than reduced | Support has been lost and what remains has descended |
| What fat grafting can contribute | The primary correction — restoring soft-tissue support where it has gone | Little as a solution on its own; it does not replace lifting when descent dominates | The softness element, alongside repositioning rather than instead of it |
| What happens if the mechanism is misread | Lifting alone can look tight without restoring softness | Volume alone can create heaviness in a face that is already carrying too much low | Treating only one mechanism leaves the result looking partly corrected |
| Why this is the first question asked | Fat grafting and lifting are not competing options — they answer different findings. Establishing whether the face is deflated, descended, or both is what determines whether volume is the treatment, an adjunct, or the wrong tool entirely | ||
The variable is not how much fat. It is where.
Almost every conversation about fat grafting starts with quantity, and quantity is the least informative part of the plan. Distribution matters more than total volume. Small amounts placed in the correct planes can improve the transitions that actually make a face read as supported — lid to cheek, cheek to nasolabial region, temple to brow, and continuity along the jawline. Overfilling a single region does the opposite: it produces an obvious result that draws attention to the area treated. The goal is harmony rather than projection, and those two objectives frequently point in different directions.
Small amounts in the right planes change the shadows
What patients notice as hollowing is largely a shadow phenomenon: light falls differently across a face that has lost soft-tissue support, and the harsher shadows read as age or fatigue. That is why placement plane matters more than placement volume. Correcting a shadow at the lid–cheek junction or in the temple can change how the whole region reads, using far less than would be needed to visibly enlarge anything. It is also why the tissues’ capacity to accept volume without heaviness is assessed as a limit in its own right, rather than treated as a target to be filled.
Retention is biology, not a specification
A portion of transferred fat will not survive, and the percentage varies between patients. Individual tissue behaviour influences retention, swelling, and how the final contour reads. This is the part of the procedure that most resembles other biologic transfers and least resembles a product.
The practical consequence is that fixed-volume promises cannot be made honestly. Donor availability may also be limited in very lean patients, and skin quality and scarring history influence predictability. None of that makes the procedure unreliable — it makes conservative, staged planning the reasonable default rather than a hedge.
A second session is something to plan for, not a failure
Because retention varies, some patients need more than one session for optimal refinement, and it is better to expect that at the outset than to discover it as a disappointment. The asymmetry that governs the plan is simple: if under-correction occurs, a second session can be considered once things have stabilised. If overfilling occurs, correction is considerably more difficult. Those two situations are not equally recoverable, which is why conservative first-session planning is the safer strategy even when a larger single-stage result is technically possible. Equally, some patients should not be over-treated at all, and recognising that is part of the same judgement.
What it does not do
It is not a guarantee of permanent volume in a specific amount. It does not replace a facelift when descent is the dominant mechanism. It does not guarantee symmetry — baseline asymmetry exists and graft behaviour can differ between the two sides.
And it is not always the right answer at all. A face that is already full, or a patient who is markedly swelling-prone, are both reasons to reconsider rather than to proceed with smaller volumes.
I do not promise a volume
I avoid fixed-volume promises, and I want to explain why rather than leave it sounding evasive. A number quoted in advance implies that the tissue will comply, and tissue does not make commitments. What I can commit to is the diagnosis, the distribution and the restraint: identifying whether the face is deflated or descended, placing volume at the transitions rather than into a region, and stopping short of what the tissues can carry rather than at the edge of it. When I plan that way, the result tends to age quietly — which is the outcome I am actually aiming for. A face that looks supported at year five is worth more than one that looks full at week six.
Recovery is a sequence, not a single date.
- Early phaseSwelling and bruising occur in donor and recipient areas
Both regions are healing, not only the face. Swelling and bruising vary between individuals, and this is the period in which the least useful conclusions are drawn about the result.
- Early-fullness phaseEarly fullness is not final fullness
The face looks fuller than it will remain. Patients who were treated conservatively often worry at this stage that too much was placed — and patients who were overfilled often feel reassured. Both readings are premature.
- Fat stabilisation phaseThe contour refines as swelling resolves and the fat stabilises
This occurs over weeks to months. I avoid fixed timelines because healing depends on individual tissue behaviour, and realistic expectations about this period are a genuine part of the treatment.
What should be weighed in the decision?
This procedure trades predictability for biology. It uses your own tissue and can last, but it cannot be specified in advance the way a manufactured product can.
- Trade-off: a portion of transferred fat will not survive, and the percentage varies between patients.
- Trade-off: fixed-volume promises cannot be made, so the plan is described in terms of distribution rather than quantity.
- Trade-off: conservative first-session planning means the result may be deliberately short of the eventual target.
- Trade-off: swelling and bruising occur in both donor and recipient areas.
- Trade-off: early fullness is misleading, and the contour only reads correctly once the fat has stabilised over weeks to months.
- Trade-off: some patients need more than one session for optimal refinement.
- Limitation: risks include asymmetry, irregularity, under- or over-correction, fat nodules, and dissatisfaction if expectations are unrealistic.
- Limitation: it is not a guarantee of permanent volume in a specific amount.
- Limitation: it does not guarantee symmetry.
- Limitation: it does not replace a facelift when descent is the dominant problem.
- Limitation: overfilling one region creates an obvious result, and correction after overfilling is more difficult than correction after under-filling.
- Limitation: donor availability may be limited in very lean patients.
- Limitation: skin quality and scarring history influence predictability.
- Limitation: individual tissue behaviour influences retention, swelling and how the final contour reads.
- Limitation: ageing continues, and the face will still change after grafting.
- Alternative: where descent dominates, lifting is the operation the anatomy calls for, with volume as an adjunct at most.
- Alternative: where predictable, reversible short-term change is the priority, manufactured fillers behave differently and may suit better.
- Alternative: where the face is already full or markedly swelling-prone, not adding volume is the better plan.
- Alternative: where more volume is wanted later, a second session after stabilisation is safer than an aggressive first one.
How to think about the decision
The decision is well founded when the mechanism has been named — deflation, descent, or both — rather than assumed from the complaint; when the tissues have been judged able to carry added volume without heaviness; when donor availability has been assessed rather than presumed; and when variable retention has been accepted as a property of the procedure rather than treated as a risk of failure.
What you should expect is improved contour and softer transitions. Not perfect symmetry, and not a fixed, guaranteed volume result. When properly indicated, facial fat grafting can restore a more balanced facial structure in a restrained way, and the best outcomes come from anatomical diagnosis, conservative volume distribution and individualised planning that respects long-term facial harmony. An in-person assessment is the safest way to define the indication, donor availability, and realistic expectations for retention and your own tissue behaviour.
Who is a good candidate for facial fat grafting?
Good candidates typically have visible volume loss or contour imbalance and want a natural, tissue-based restoration. I assess whether the face is deflated, descended, or both, and whether the tissues can carry added volume without heaviness. A good candidate understands that retention varies with individual tissue behaviour and that results mature over time.
How is fat grafting different from HA fillers?
Fillers are manufactured gels with predictable short-term behaviour and reversibility. Fat grafting is biologic transfer with variable retention and more downtime. The best choice depends on goals, anatomy, and tolerance for variability.
Is the amount of fat the main variable?
No. Distribution matters more than total volume. Small amounts placed in the correct planes can improve transitions such as lid–cheek, cheek–nasolabial, temple–brow and jawline continuity, whereas overfilling one region is the main reason a result looks obvious.
How long does fat grafting last?
A portion of fat that survives can be long-lasting, but the exact retention is variable. I avoid fixed promises. Ageing continues, and the face will still change.
When is fat grafting not the right answer?
It is not always the right answer when the face is already full, when swelling tendency is high, or when descent is the dominant problem that requires lifting.
What if I am very lean?
Donor availability may be limited in very lean patients, which can constrain what the plan can achieve. That is assessed at consultation rather than discovered during surgery.
How variable is recovery?
Swelling and bruising vary. Early fullness can be misleading. I avoid fixed timelines because healing depends on individual tissue behaviour.
What are the main risks?
Risks include asymmetry, irregularity, under- or over-correction, fat nodules, and dissatisfaction if expectations are unrealistic. Conservative planning reduces risk.
Can fat grafting be combined with facelift surgery?
Yes, often. Combining repositioning with volume restoration can create a more natural result in selected patients.
What if I want more volume later?
A second session can be considered after stabilisation. Staging is often safer than aggressive first-session volume.
Will it look natural?
It should when volume is distributed conservatively and transitions are respected. Overfilling is the main reason results look obvious.
What should I realistically expect?
You should expect improved contour and softer transitions. You should not expect perfect symmetry or a fixed, guaranteed volume result.
